Interim Analysis in Clinical Trials: Strategies, Regulatory Considerations, and Best Practices
Interim Analysis refers to the examination of accumulating data from an ongoing clinical trial before its formal completion. It allows for early decisions regarding continuation, modification, or termination of the study based on predefined statistical and clinical criteria. Interim analyses are essential for protecting participant welfare, optimizing trial efficiency, and informing regulatory decisions under strict control mechanisms to maintain study integrity.
Click to read the full article.